Viewing Study NCT01596218


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-01-25 @ 11:39 PM
Study NCT ID: NCT01596218
Status: COMPLETED
Last Update Posted: 2018-07-26
First Post: 2012-05-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Brentuximab Vedotin for Steroid Refractory GvHD
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module